Treatment of Olfactory Disorders After SARS – CoViD 2 Virus Infection
Authors:
Open Access
- 28 March 2023
- journal article
- research article
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 103 (1_suppl) , 48S-53S
Abstract
Objective: The benefit of a nasal corticosteroid in the treatment of persistent post-infectious smell disorders is not as clear in previous studies as is assumed for olfactory training. This study would therefore like to describe the treatment strategies using the example of a persistent olfactory dysfunction as a result of a proven infection with SARS-CoViD-2-virus. Methods: Twenty patients (average age of 33.9 ± 11.9 years) with hyposmia were included in this study from December 2020 to July 2021. Every second patient received additionally a nasal corticosteroid. The two resulting randomized groups of equal size were screened with the TDI test, a 20-item taste powder test for the assessment of retronasal olfaction and otorhinolaryngological examination. The patients were asked to train twice daily using a standardized odor training kit and followed up after 2 months and 3 months, respectively. Results: We documented a significant overall improvement in olfactory ability over the investigation period in both groups. While the TDI score steadily increased on average under the combination therapy, the rise under olfactory training alone was initially steeper. This short-term interaction effect over mean two months was not statistically significant. According to Cohen, however, a moderate effect (eta 2 = 0.055, Cohen`s d = 0.5) can still be assumed. This effect could be explained by a possibly higher compliance at the beginning of the sole olfactory training due to the lack of further drug treatment offers. When the training intensity decreases, the recovery of the sense of smell stagnates. Adjunctive therapy ultimately outweighs this short-term benefit. Conclusions: The results reinforce the recommendation of early and consistent olfactory training on patients with dysosmia due to COVID-19. For continuous improvement of the sense of smell, an accompanying topical treatment seems at least to be worth consideration. The results should be optimized with larger cohorts and using new objective olfactometric methods.Keywords
This publication has 32 references indexed in Scilit:
- How common are taste and smell abnormalities in COVID-19? A systematic review and meta-analysisJournal of Taibah University Medical Sciences, 2021
- COVID-19 and anosmia: The story so farEar, Nose & Throat Journal, 2021
- Long-term persistence of olfactory and gustatory disorders in COVID-19 patientsClinical Microbiology and Infection, 2021
- Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trialAmerican Journal of Otolaryngology, 2021
- Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, ItalyEar, Nose & Throat Journal, 2020
- Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patientsEuropean Archives of Oto-Rhino-Laryngology, 2020
- A New Method for Assessment of Retronasal Olfactory FunctionThe Laryngoscope, 2020
- Updated Sniffin’ Sticks normative data based on an extended sample of 9139 subjectsEuropean Archives of Oto-Rhino-Laryngology, 2018
- Active Olfactory Training for the treatment of Smelling DisordersEar, Nose & Throat Journal, 2012
- Is It Really Robust?Methodology, 2010